Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-05-03 209148
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-16 215737
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-09 215740
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-18 2024-05-09 216466
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-08 2024-03-07 218983
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-07 2024-05-09 221546
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-05-09 222572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-05-09 223856
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-05-09 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-05-16 2024-05-16 228143
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-13 2020-02-13 1674
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-10 2017-09-19 9805
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975

Showing 2641 to 2660 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250